Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02140645 · ClinicalTrials.gov registry record
Ascertainment of EMR-based Clinical Covariates Among Patients Receiving Oral and Non-insulin Injected Hypoglycemic Therapy
A clinical trial, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- 166,613
- Enrollment target
NCT02140645: Completed study, sponsored by Boehringer Ingelheim.
NCT02140645 is a clinical trial that has completed, run by Boehringer Ingelheim. The registered enrollment target is 166,613 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02140645 has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- 166,613 participants
- Enrollment target
Study Summary
The objective of this study is to identify EMR-based clinical covariates and quantify their association with the prescribing of each specific type 2 diabetes (T2DM) medication under investigation. This will include an assessment of how well these covariates are captured through claims data proxies, and their potential to confound comparative research of T2DM medications.
Primary Outcome
The missing EMR characteristic smoking defined as current, unknown, versus past/never smoker. The associations between claims-based covariates and missingness on EMR characteristics were investigated by estimating a logistic regression model (and multinomial logistic regression, depending on the number of categories for the EMR characteristic) for each EMR characteristic where an indicator for missing the EMR characteristic smoking was the dependent variable and all claims-based covariates were
Interventions
- DRUG linagliptin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166,613 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-03 |
What the finished NCT02140645 record still lists
NCT02140645 is an observational study that tracks outcomes without assigning an intervention. Its 166,613 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which linagliptin is the first listed.
NCT02140645 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02140645 about?
NCT02140645 is a clinical study titled "Ascertainment of EMR-based Clinical Covariates Among Patients Receiving Oral and Non-insulin Injected Hypoglycemic Therapy". The objective of this study is to identify EMR-based clinical covariates and quantify their association with the prescribing of each specific type 2 diabetes (T2DM) medication under investigation. This will include an assessment of how well these covariates are captured through claims data proxies, ...
What is the current status of trial NCT02140645?
This trial is currently completed. The enrollment target is 166,613 participants. The study started on 2014-05. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02140645?
The interventions under investigation include: linagliptin (DRUG).
Who is sponsoring clinical trial NCT02140645?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06917339 · 156,000 participants
Retrospective Analyses of TrakStar Database
- NCT06090578 · 180,000 participants · NA
TabCAT Brain Health Assessment in Primary Care
- NCT06232551 · 152,000 participants · NA
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
- NCT05994482 · 130,000 participants
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia